Assessment of prognosis and responsiveness to immunotherapy in colorectal cancer patients based on the level of immune cell infiltration
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study developed a new model to predict colon cancer patient survival based on immune cell gene co-expression. The model identifies risk groups with different prognoses and chemotherapy responses, aiding in personalized treatment strategies.
Area Of Science
- Oncology
- Immunology
- Bioinformatics
Background
- Colorectal cancer (CRC) prognosis is influenced by tumor immune microenvironment.
- Accurate prognostic models are crucial for guiding CRC treatment decisions.
Purpose Of The Study
- To develop a prognostic risk assessment model for colon cancer patients using immune cell co-expression networks.
- To evaluate the model's ability to predict overall survival and immunotherapy efficacy.
Main Methods
- Utilized The Cancer Genome Atlas (TCGA) database for gene expression and clinical data.
- Applied weighted gene co-expression network analysis (WGCNA) to identify immune-related gene modules.
- Constructed and validated a prognostic model using LASSO-Cox regression and survival analysis.
Main Results
- A novel prognostic model demonstrated robust predictive accuracy for patient survival.
- High-risk patients showed increased immune infiltration and tumor mutation burden, but no significant difference in immunotherapy response.
- Distinct chemotherapy responses to 39 drugs were observed between risk subgroups.
Conclusions
- High immune infiltration correlates with unfavorable prognosis in colon cancer.
- The developed model accurately predicts survival and aids in personalized colon cancer management.
- Findings provide insights for improved prognostication and treatment strategies in colon cancer.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
